CRISPR therapies help rectify malfunctioning genes that cause genetic disorders such as sickle cell anemia, cystic fibrosis and various cancers. The technology allows modification of genes with high precision and efficiency compared to previous techniques.
The global Crispr Genomic Cure Market is estimated to be valued at US$ 1.84 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key Trends:
Rising disease burden has accelerated the growth of Crispr Genomic Cure Market. With increasing incidences of various genetic disorders, there has been growing demand for efficient treatment options. CRISPR technology provides potential cure by precisely editing the malfunctioning genes responsible for diseases. This has boosted research activities focused on developing Crispr based therapies. Several clinical trials are underway to evaluate efficacy and safety of Crispr treatments. Potential success of ongoing studies can further fuel the market growth.
Segment Analysis
The CRISPR Genomic Cure Market is dominated by the CRISPR gene editing sub segment which holds around 60% of the total market share. CRISPR gene editing is gaining high prominence owing to its precise and simple method of editing genomes. It allows scientists to simply cut and paste desirable traits into DNA, which has led to its widespread adoption over other complex gene editing techniques.
Key Takeaways
The global CRISPR Genomic Cure Market growth is expected to witness high growth. The global Crispr Genomic Cure Market is estimated to be valued at US$ 1.84 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030.
Regional analysis related content comprises:
North America is currently the largest market for Crispr Genomic Cures in terms of revenue. This is attributed to high adoption rates for innovative genomic technologies along with presence of prominent market participants in the US. However, Asia Pacific is poised to offer most lucrative growth opportunities during the forecast period. Countries such as China and India are witnessing significant investments to promote genomics research from both public and private sectors. Additionally, the rising geriatric population base susceptible to chronic conditions in Asia Pacific will further aid the market expansion.
Key players related content comprises:
Key players operating in the Crispr Genomic Cure Market are Marriott International, Hilton Worldwide Holdings Inc., InterContinental Hotels Group PLC, and Four Seasons Hotels and Resorts. Marriott International dominates the overall market owing to its robust global presence and diversified brand portfolio catering to all hotel segments.
For more insights, read- https://www.ukwebwire.com/crispr-genomic-cure-market-trends-size-and-share-analysis/
For more details on the report, Read- https://dailynewsmotion.weebly.com/report-blog/luxury-travel-market-is-estimated-to-witness-high-growth-owing-to-increased-adventurism
Comments
0 comment